Leverage is moderate with D/E at 0.69 and total debt of $5.3B, but goodwill and net PPE together represent over 72% of total assets, warranting scrutiny of asset quality.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 3.68B | 3.41B | 2.82B | 2.81B | 2.54B | 2.26B | 3.28B | 1.92B | 1.94B | 1.8B | 1.68B | 1.72B | 1.62B | 1.43B | 1.41B | 1.36B | 1.33B | 796.2M | 789.42M | 774.85M | 728.51M | 608.3M | 808.92M | 645.79M | 593.62M | 548.26M | 476.45M | 403.2M | 319.6M | 230M | 194M |
| Cash & Short-Term Investments | 138.8M | 137.8M | 125.98M | 119.44M | 102.82M | 115.3M | 1.22B | 61.27M | 105.22M | 74.42M | 33.75M | 61.23M | 32.07M | 17.24M | 23.47M | 41.23M | 29.47M | 9.18M | 5.46M | 16.35M | 14.94M | 7.96M | 33.13M | 34.86M | 17.75M | 22.85M | 10.54M | 6.2M | 1.3M | 300K | 300K |
| Cash Only | 138.8M | 137.8M | 125.98M | 119.44M | 102.82M | 115.3M | 1.22B | 61.27M | 105.22M | 74.42M | 33.75M | 61.23M | 32.07M | 17.24M | 23.47M | 41.23M | 29.47M | 9.18M | 5.46M | 16.35M | 14.94M | 7.96M | 33.13M | 34.86M | 17.75M | 22.85M | 10.54M | 6.2M | 1.3M | 300K | 300K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.8B | 2.6B | 2.18B | 2.24B | 2.02B | 1.75B | 1.73B | 1.56B | 1.51B | 1.5B | 1.44B | 1.3B | 1.28B | 1.12B | 1.07B | 969.8M | 837.82M | 602.56M | 625.44M | 627.19M | 595.01M | 499.73M | 552.54M | 503.93M | 474.76M | 418.08M | 376.6M | 307.3M | 256.4M | 180.3M | 145.4M |
| Days Sales Outstanding | 54.07 | 54.7 | 50.22 | 57.2 | 54.96 | 50.43 | 54.6 | 50.07 | 51.16 | 52.63 | 53.8 | 52.57 | 58.05 | 55.97 | 55.96 | 47.2 | 54.92 | 42.28 | 45.45 | 48.18 | 51.82 | 46.35 | 51.21 | 50.48 | 53.17 | 53.72 | 61.3 | 54.92 | 49.93 | 45.62 | 44.59 |
| Inventory | 234.09M | 232.11M | 220.94M | 216.99M | 218.52M | 206.84M | 190.42M | 159.89M | 148.21M | 136.18M | 125.36M | 116.04M | 108.11M | 101.78M | 99M | 96.78M | 94.33M | 84.27M | 76.04M | 72.4M | 64.53M | 52.84M | 60.73M | 61.74M | 58.22M | 0 | 45.52M | 41.2M | 38.8M | 28.2M | 22M |
| Days Inventory Outstanding | 49.88 | 51.07 | 50.79 | 51.67 | 54.1 | 52.9 | 53.96 | 46.64 | 46.29 | 44.98 | 44.37 | 43.48 | 44.06 | 45.24 | 45.19 | 43.85 | 48.03 | 10.59 | 9.82 | 39.66 | 42.99 | 9.11 | 11.35 | 20.13 | 17.52 | - | 20.34 | 31.65 | 32.33 | 17.91 | 17.49 |
| Other Current Assets | 505.32M | 381.57M | 291.61M | 236.66M | 198.28M | 194.78M | 138.03M | 133.93M | 174.47M | 86.5M | 82.71M | 238.61M | 192.22M | 196.35M | 217.83M | 257.1M | 369.49M | 100.19M | 82.48M | 58.91M | 54.03M | 47.77M | 162.53M | 45.26M | 42.89M | 107.33M | 43.79M | 48.5M | 23.1M | 21.2M | 26.3M |
| Total Non-Current Assets | 12.26B | 12.55B | 11.65B | 11.16B | 10.96B | 10.83B | 10.2B | 9.75B | 9.33B | 8.96B | 8.64B | 7.9B | 7.36B | 6.88B | 6.79B | 6.3B | 6.2B | 3.17B | 2.95B | 2.83B | 2.55B | 2.25B | 2.21B | 2.13B | 1.74B | 1.62B | 1.27B | 1.09B | 1.13B | 855.3M | 771.8M |
| Property, Plant & Equipment | 7.51B | 7.38B | 6.99B | 6.56B | 6.37B | 6.24B | 5.71B | 5.34B | 4.85B | 4.57B | 4.33B | 3.84B | 3.68B | 3.44B | 3.38B | 3.29B | 3.25B | 2.32B | 2.1B | 1.93B | 1.69B | 1.43B | 1.45B | 1.3B | 1.17B | 1.03B | 875.63M | 777.1M | 808.8M | 663.1M | 567.6M |
| Fixed Asset Turnover | 2.00x | 2.35x | 2.26x | 2.18x | 2.10x | 2.03x | 2.02x | 2.13x | 2.22x | 2.28x | 2.25x | 2.36x | 2.19x | 2.12x | 2.06x | 2.28x | 1.71x | 2.25x | 2.39x | 2.46x | 2.49x | 2.75x | 2.72x | 2.79x | 2.78x | 2.75x | 2.56x | 2.63x | 2.32x | 2.18x | 2.10x |
| Goodwill | 3.98B | 3.99B | 3.93B | 3.93B | 3.91B | 3.96B | 3.88B | 3.87B | 3.84B | 3.83B | 3.78B | 3.6B | 3.29B | 3.05B | 3.04B | 2.63B | 2.59B | 732.68M | 732.94M | 750.39M | 719.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 75.88M | 76.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 686.21M | 619.06M | 442.5M | 410.32M | 372.63M | 316.78M | 276M | 279.1M | 149.8M | 150.3M |
| Long-Term Investments | 346.23M | 346.23M | 318.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 702.35M | 254.5M | 216.19M | 579.73M | 605.89M | 579.9M | 579.97M | 523.15M | 629.83M | 563.83M | 520.13M | 465.05M | 388.4M | 388.21M | 374.35M | 384.76M | 353.94M | 120.34M | 119.82M | 149.5M | 143.46M | 134.55M | 146.79M | 380.09M | 152M | 216.5M | 73.52M | 41.7M | 40.6M | 42.4M | 53.9M |
| Total Assets | 15.94B | 15.96B | 14.47B | 13.97B | 13.49B | 13.09B | 13.48B | 11.67B | 11.27B | 10.76B | 10.32B | 9.62B | 8.97B | 8.31B | 8.2B | 7.67B | 7.53B | 3.96B | 3.74B | 3.61B | 3.28B | 2.86B | 3.02B | 2.77B | 2.33B | 2.17B | 1.74B | 1.5B | 1.45B | 1.09B | 965.8M |
| Asset Turnover | 1.15x | 1.09x | 1.09x | 1.02x | 0.99x | 0.97x | 0.86x | 0.98x | 0.96x | 0.97x | 0.95x | 0.94x | 0.90x | 0.88x | 0.85x | 0.98x | 0.74x | 1.31x | 1.34x | 1.32x | 1.28x | 1.38x | 1.30x | 1.31x | 1.40x | 1.31x | 1.29x | 1.36x | 1.29x | 1.33x | 1.23x |
| Asset Growth % | 28.93% | 10.28% | 3.6% | 3.51% | 3.06% | -2.84% | 15.5% | 3.58% | 4.68% | 4.3% | 7.3% | 7.14% | 7.97% | 1.35% | 6.99% | 1.82% | 89.89% | 5.93% | 3.71% | 10.12% | 14.63% | -5.43% | 9.02% | 19.05% | 7.4% | 24.46% | 16.31% | 3.45% | 33.43% | 12.37% | 29.1% |
| Total Current Liabilities | 3.3B | 3.24B | 2.21B | 2.01B | 1.91B | 1.98B | 2.48B | 1.56B | 1.45B | 1.85B | 1.32B | 1.1B | 1.18B | 1.06B | 894.06M | 836.93M | 826.3M | 582.82M | 561.13M | 487.71M | 502.45M | 524.17M | 469.66M | 395.75M | 370.41M | 322.72M | 248.84M | 217.2M | 170.1M | 160.5M | 140.1M |
| Accounts Payable | 2.45B | 750.13M | 632M | 613.97M | 636.6M | 658.9M | 570.52M | 446.96M | 445.65M | 441.98M | 439.67M | 366.24M | 336.45M | 276.91M | 247.03M | 228.04M | 252.49M | 194.97M | 192.08M | 175.22M | 190.16M | 421.29M | 190.18M | 178.82M | 170.47M | 144.16M | 113.29M | 105.3M | 165.7M | 153.1M | 57.1M |
| Days Payables Outstanding | 426.74 | 165.04 | 145.28 | 146.2 | 157.6 | 168.52 | 161.66 | 130.37 | 139.19 | 145.98 | 155.6 | 137.23 | 137.1 | 123.1 | 112.76 | 103.34 | 128.55 | 24.51 | 24.79 | 95.98 | 126.68 | 72.67 | 35.53 | 58.32 | 51.31 | 78.77 | 50.63 | 80.9 | 138.05 | 97.22 | 45.39 |
| Short-Term Debt | 842.77M | 821.39M | 40.06M | 126.69M | 81.45M | 48.41M | 332M | 87.55M | 63.45M | 545.62M | 105.89M | 62.72M | 68.32M | 99.31M | 2.59M | 2.48M | 3.45M | 2.57M | 8.71M | 3.12M | 1.94M | 5.19M | 16.97M | 10.87M | 8.25M | 2.44M | 689K | 3.5M | 4.1M | 5.7M | 6.9M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 5.38M | 2.4M | 6K | 376.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 984.56M | 622.63M | 549.47M | 470.86M | 466.35M | 410.17M | 524.63M | 472.53M | 343.22M | 275.29M | 245.12M | 323.43M | 278.21M | 260.5M | 235.91M | 521.03M | 354.24M | 0 | 287.73M | 0 | -243.69M | 21.12M | 0 | 0 | 0 | 134.86M | 108.4M | 300K | 1.7M | 76.1M |
| Current Ratio | 1.12x | 1.05x | 1.27x | 1.40x | 1.33x | 1.14x | 1.32x | 1.23x | 1.34x | 0.97x | 1.28x | 1.56x | 1.37x | 1.35x | 1.57x | 1.63x | 1.61x | 1.37x | 1.41x | 1.59x | 1.45x | 1.16x | 1.72x | 1.63x | 1.60x | 1.70x | 1.91x | 1.86x | 1.88x | 1.43x | 1.38x |
| Quick Ratio | 1.04x | 0.98x | 1.17x | 1.29x | 1.21x | 1.04x | 1.25x | 1.12x | 1.24x | 0.90x | 1.18x | 1.46x | 1.27x | 1.26x | 1.46x | 1.52x | 1.50x | 1.22x | 1.27x | 1.44x | 1.32x | 1.06x | 1.59x | 1.48x | 1.45x | 1.70x | 1.73x | 1.67x | 1.65x | 1.26x | 1.23x |
| Cash Conversion Cycle | -322.79 | -59.27 | -44.27 | -37.33 | -48.54 | -65.19 | -53.11 | -33.66 | -41.74 | -48.38 | -57.43 | -41.19 | -35 | -21.88 | -11.62 | -12.29 | -25.6 | 28.36 | 30.48 | -8.14 | -31.87 | -17.21 | 27.02 | 12.3 | 19.38 | - | 31.01 | 5.67 | -55.8 | -33.7 | 16.69 |
| Total Non-Current Liabilities | 4.98B | 5.31B | 5.5B | 5.75B | 5.61B | 4.91B | 4.59B | 4.52B | 4.35B | 3.86B | 4.39B | 3.96B | 3.76B | 3.73B | 4.31B | 4.26B | 4.47B | 1.39B | 1.41B | 1.6B | 1.2B | 969.56M | 1.15B | 1.13B | 901.02M | 912.06M | 656.17M | 523.6M | 521.6M | 398.2M | 372.7M |
| Long-Term Debt | 4.08B | 4.26B | 4.46B | 4.79B | 4.73B | 4.14B | 3.52B | 3.9B | 3.94B | 3.49B | 4.03B | 3.37B | 3.21B | 3.21B | 3.73B | 3.65B | 3.91B | 956.43M | 990.66M | 1.01B | 821.36M | 637.65M | 852.23M | 868.57M | 680.51M | 718.83M | 548.06M | 419.2M | 418.2M | 272.5M | 275.6M |
| Capital Lease Obligations | 1.11B | 426.1M | 376.24M | 382.56M | 395.52M | 304.62M | 278.3M | 270.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 441.61M | 435.14M | 0 | 0 | 0 | 0 | 5.58M | 25.07M | 49.66M | 54.96M | 88.12M | 315.9M | 282.21M | 239.15M | 183.75M | 209.59M | 173.35M | 60.09M | 12.44M | 40.02M | 35.89M | 42.71M | 50.21M | 41.84M | 14.27M | 28.84M | 36.38M | 30.6M | 23.3M | 500K | 0 |
| Other Non-Current Liabilities | 559.96M | 187.11M | 655.81M | 584.01M | 487.67M | 464.76M | 458.55M | 329.93M | 361.81M | 306.3M | 275.17M | 278.83M | 268.56M | 284.59M | 395.36M | 401.91M | 380.65M | 375.58M | 407.65M | 554.94M | 340.81M | 289.19M | 243.62M | 216.09M | 206.24M | 164.39M | 71.73M | 73.8M | 80.1M | 125.2M | 97.1M |
| Total Liabilities | 8.28B | 8.55B | 7.71B | 7.77B | 7.52B | 6.9B | 7.07B | 6.09B | 5.8B | 5.7B | 5.71B | 5.06B | 4.94B | 4.79B | 5.2B | 5.1B | 5.29B | 1.97B | 1.97B | 2.09B | 1.7B | 1.49B | 1.62B | 1.52B | 1.27B | 1.23B | 905.01M | 740.8M | 691.7M | 558.7M | 512.8M |
| Total Debt | 5.26B | 5.51B | 4.96B | 5.37B | 5.27B | 4.56B | 4.19B | 4.31B | 4B | 4.04B | 4.14B | 3.43B | 3.28B | 3.31B | 3.73B | 3.65B | 3.92B | 959M | 999.37M | 1.01B | 823.3M | 642.85M | 869.2M | 879.44M | 688.77M | 721.27M | 548.75M | 422.7M | 422.3M | 278.2M | 282.5M |
| Net Debt | 5.12B | 5.37B | 4.83B | 5.25B | 5.17B | 4.44B | 2.97B | 4.25B | 3.89B | 3.97B | 4.1B | 3.37B | 3.25B | 3.29B | 3.71B | 3.61B | 3.89B | 949.82M | 993.91M | 995.55M | 808.36M | 634.88M | 836.07M | 844.57M | 671.02M | 698.42M | 538.21M | 416.5M | 421M | 277.9M | 282.2M |
| Debt / Equity | 0.69x | 0.74x | 0.73x | 0.87x | 0.88x | 0.74x | 0.65x | 0.77x | 0.73x | 0.80x | 0.90x | 0.75x | 0.81x | 0.94x | 1.24x | 1.42x | 1.75x | 0.48x | 0.56x | 0.67x | 0.52x | 0.47x | 0.62x | 0.70x | 0.65x | 0.77x | 0.66x | 0.56x | 0.56x | 0.53x | 0.62x |
| Debt / EBITDA | 1.95x | 2.11x | 2.19x | 3.08x | 3.32x | 2.40x | 2.24x | 2.53x | 2.46x | 2.34x | 2.44x | 2.07x | 2.28x | 2.45x | 2.98x | 3.06x | 5.37x | 1.32x | 1.65x | 1.83x | 1.70x | 1.35x | 1.82x | 0.90x | 1.52x | 1.86x | 1.77x | 1.57x | 1.60x | 1.35x | 1.60x |
| Net Debt / EBITDA | 1.90x | 2.06x | 2.13x | 3.01x | 3.26x | 2.34x | 1.59x | 2.49x | 2.39x | 2.29x | 2.42x | 2.03x | 2.26x | 2.43x | 2.96x | 3.03x | 5.33x | 1.31x | 1.64x | 1.80x | 1.67x | 1.33x | 1.75x | 0.86x | 1.48x | 1.80x | 1.73x | 1.54x | 1.59x | 1.35x | 1.60x |
| Interest Coverage | 13.99x | 13.51x | 8.96x | 5.53x | 7.80x | 16.15x | 12.45x | 7.55x | 7.63x | 8.88x | 10.84x | 12.00x | 8.94x | 7.39x | 5.65x | 4.29x | 6.40x | 11.37x | 7.73x | 3.43x | 8.35x | 9.54x | 4.84x | 21.88x | 6.28x | 2.51x | 6.60x | 3.68x | 4.40x | 6.47x | 3.55x |
| Total Equity | 7.66B | 7.41B | 6.76B | 6.2B | 5.97B | 6.2B | 6.41B | 5.58B | 5.47B | 5.06B | 4.61B | 4.55B | 4.03B | 3.52B | 3B | 2.57B | 2.24B | 1.99B | 1.77B | 1.52B | 1.58B | 1.36B | 1.41B | 1.25B | 1.06B | 933.81M | 837.36M | 757.2M | 756.4M | 526.6M | 453M |
| Equity Growth % | 36.27% | 9.56% | 9.04% | 3.88% | -3.68% | -3.25% | 14.75% | 2.07% | 8.14% | 9.79% | 1.21% | 12.93% | 14.56% | 17.27% | 16.95% | 14.75% | 12.36% | 12.37% | 16.7% | -3.76% | 15.5% | -3% | 12.53% | 18.23% | 13.27% | 11.52% | 10.59% | 0.11% | 43.64% | 16.25% | 52.17% |
| Book Value per Share | 127.71 | 114.94 | 99.61 | 88.44 | 80.86 | 74.06 | 74.85 | 62.70 | 58.35 | 52.51 | 46.83 | 45.20 | 40.09 | 35.41 | 30.71 | 26.03 | 22.82 | 20.24 | 17.45 | 14.16 | 13.61 | 10.89 | 10.85 | 9.61 | 7.88 | 6.95 | 6.46 | 5.92 | 5.68 | 3.97 | 3.69 |
| Total Shareholders' Equity | 7.51B | 7.28B | 6.67B | 6.15B | 5.92B | 6.09B | 6.32B | 5.5B | 5.39B | 4.99B | 4.53B | 4.25B | 3.74B | 3.25B | 2.71B | 2.3B | 1.98B | 1.75B | 1.54B | 1.52B | 1.4B | 1.21B | 1.22B | 1.09B | 917.46M | 807.9M | 716.57M | 641.6M | 627M | 526.6M | 453M |
| Common Stock | 7.51B | 611K | 650K | 672K | 710K | 771K | 851K | 867K | 914K | 942K | 966K | 983K | 987K | 983K | 976K | 966K | 971K | 970K | 494K | 525K | 538K | 539K | 577K | 580K | 589K | 598K | 299K | 300K | 0 | 0 | 0 |
| Retained Earnings | 0 | 7.99B | 7.37B | 6.8B | 5.93B | 6.06B | 6.27B | 5.47B | 5.38B | 4.98B | 4.89B | 4.57B | 4.02B | 3.5B | 2.96B | 2.49B | 2.13B | 1.88B | 1.67B | 1.6B | 1.48B | 1.26B | 1.22B | 1.05B | 851.42M | 676.06M | 576.32M | 483M | 405.2M | 325.6M | 258.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -717.57M | -706.5M | -650.6M | -9.67M | 30.29M | 48.12M | 31.89M | 4.24M | 7.18M | -359.02M | -317.86M | -280.43M | -250.34M | -250.06M | -198.69M | -148.19M | -129.88M | -123.62M | -82.65M | -82.06M | -51.88M | -21.41M | -2.83M | -18.69M | -6.16M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 141.43M | 133.62M | 96.61M | 52.91M | 49.46M | 108.51M | 89.39M | 79.1M | 80.82M | 68.62M | 73.69M | 302.02M | 294.69M | 268.36M | 286.91M | 269.03M | 256.76M | 238.47M | 226.74M | 0 | 174.06M | 159.88M | 186.54M | 159.55M | 140.25M | 125.91M | 120.79M | 115.6M | 129.4M | 0 | 0 |
Labor cost inflation
Total assets grew from $14.0B in 2024Q1 to $15.9B in 2026Q2, while equity rose to $7.5B, indicating steady balance sheet strengthening, as per quarterly filings.
The sequential increase in total assets, driven largely by PPE expansion from $6.6B to $7.5B, suggests ongoing investment in facility capacity. Equity growth from $6.3B to $7.5B over the same period, coupled with a stable D/E ratio around 0.7, implies that asset growth is being funded through retained earnings rather than excessive debt, which may signal improving financial flexibility.
Total debt remained relatively flat at $5.3B in 2026Q2, with D/E at 0.69, down from 0.84 in 2024Q1, indicating conservative leverage management, as reported in financial statements.
The slight reduction in D/E, despite a modest increase in absolute debt, reflects the growth in equity from retained earnings. This suggests that the company is not aggressively levering up to fund expansion, which may reduce refinancing risk. However, the absolute debt level of $5.3B remains substantial, and interest coverage should be monitored given the rising rate environment, though the current leverage appears manageable.
Net PPE increased from $6.6B in 2024Q1 to $7.5B in 2026Q2, while goodwill remained stable at $4.0B, underscoring the capital-intensive nature of UHS's operations, based on reported balance sheet data.
The consistent growth in PPE indicates ongoing investment in hospital facilities and equipment, which is typical for the healthcare provider industry. Goodwill, representing about 25% of total assets, has not increased recently, suggesting that the company is not pursuing large acquisitions that could impair value. The asset mix, with a heavy tilt toward fixed assets, implies high fixed costs and a need for consistent utilization to generate returns.
Retained earnings rose from $6.9B in 2024Q1 to $8.0B in 2025Q4, while equity reached $7.5B in 2026Q2, indicating strong internal capital generation, as per SEC filings.
The increase in retained earnings, despite significant share repurchases ($320.8M in 2026Q2), suggests that net income is being reinvested into the business. The dual-class structure may allow management to prioritize long-term growth over short-term returns, which could be beneficial for stability. However, the aggressive buyback program, while returning capital to shareholders, may also signal limited high-return investment opportunities, which warrants monitoring.
Current ratio improved to 1.12 in 2026Q2 from 1.05 in 2025Q4, but cash remains low at $138.8M, suggesting a thin liquidity cushion, as reported in quarterly data.
The current ratio above 1 indicates that current assets exceed current liabilities, but the absolute cash balance is minimal relative to total assets and likely operating expenses. This suggests that UHS relies on operating cash flow and access to credit markets rather than a large cash reserve. Given the capital-intensive nature of the business and potential for unexpected costs, the low cash buffer may increase vulnerability to short-term shocks, though the stable operating cash flow provides some comfort.
Goodwill of $4.0B and net PPE of $7.5B together represent over 72% of total assets, potentially masking the true economic value of the asset base, based on reported figures.
The significant proportion of goodwill and PPE suggests that a large portion of the balance sheet is tied up in intangible and fixed assets that may not be easily liquidated. While goodwill has remained stable, any future impairment could negatively impact equity. Additionally, the high PPE investment implies a need for continuous maintenance capital expenditure, which could pressure free cash flow if reimbursement rates decline. Investors should scrutinize the realizability of these assets, especially in a changing healthcare environment.
Quick answers to the most common questions about buying UHS stock.
As of 2025, Universal Health Services, Inc. (UHS) had total assets of $15.96B including $3.41B in current assets.
Universal Health Services, Inc. (UHS) carries total debt of $5.51B, offset by $137.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Universal Health Services, Inc. (UHS) has total shareholders' equity (book value) of $7.28B ($114.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Universal Health Services, Inc. (UHS) reported a current ratio of 1.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.